Atlas Trials

Real-world Study of Sunvozertinib Treatment in Advanced EGFR-Mutant NSCLC After EGFR-TKI Treatment Failure

Clinical trial NCT06786208 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06786208
Sponsor
Henan Cancer Hospital
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Non Small Cell Lung Cancer
Start date
2025-02-01
Primary completion
2025-12-30
Enrollment
55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.